Blood test for Alzheimer's goes on sale without FDA approval
St. Louis-based C2N Diagnostics has released a blood test that it says can detect Alzheimer's disease. The test is not yet FDA approved, and is not covered by insurance, costing up to $1,250. Northwell Health internal medicine specialist Dr. Karen Abrashkin joins CBSN's Anne-Marie Green to talk about the latest development in the fight against Alzheimer's, which affects nearly 6 million Americans.
UP NEXT
UP NEXT
-
International Olympic Committee denies reports that Tokyo Summer Games will be canceled
CBS News
-
How a national mask mandate could save the U.S. economy $1 trillion
CBS News
-
Biden signing executive orders on economic relief amid pandemic
CBS News
-
Doctor discusses emergence of more infectious coronavirus variants, vaccine efficacy
CBS News
-
President Biden making environmental issues and climate change a priority
CBS News
-
California student in viral video details hardships that shaped her journey to Harvard University
CBS News
-
Biden administration attempts to reset America
CBS News
-
Doctor discusses Biden's COVID-19 plan and latest vaccine guidance
CBS News
-
Biden administration issues 100-day moratorium on deportations
CBS News
-
Biden says he will seek to rejoin Iran nuclear deal as a starting point
CBS News
-
President Biden dissolves controversial 1776 Commission
CBS News
-
Trump faces legal challenges after leaving White House
CBS News
-
Sacha Baron Cohen on "Borat" sequel, playing activist Abbie Hoffman in "The Trial of the Chicago 7"
CBS News
-
Biden takes on economic relief after signing COVID-19 executive orders
CBS News
-
Some health care workers hesitant to get COVID-19 vaccine, complicating public health efforts
CBS News
-
WorldView: Trapped Chinese gold miners; Vatican banker convicted
CBS News